Estimation of measurement uncertainty (MU) has been extensively addressed in documents from standard authorities. In microbiology, bacterial counts are log transformed to get a more normal distribution. Unfortunately, the difference between using original and log-transformed data appears to not have been investigated even in publications focusing on MU estimation. Statistical formulae inferencing and estimation of MU using real bacterial enumeration datasets. Both mean and SD calculated from original data carry the same scale and unit as the original data. However, the mean of log-transformed data becomes a geometric mean in log, and the SD becomes the logarithm of a ratio. Furthermore, calculation of RSD obtained by dividing the SD by the mean is meaningless and misleading for log-transformed data. The ratio, the antilog of the SD of log-transformed data, copes with multiplicative and divisive relationships to geometric mean (without log), instead of the arithmetic mean. The ratio can be converted to an analog ratio, which is similar or almost identical to the RSD of the untransformed data, especially when the within-subject variation is small. When MU is estimated from multiple samples with different measurands, the calculated RSD of original data is independent of the mean and can be pooled; however, for log-transformed data, the SD can be combined to estimate the common uncertainty. Calculation and use of RSD of log-transformed data are meaningless and misleading. Procedures outlining the estimation and interpretation of MU from log-transformed data require re-evaluation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5740/jaoacint.18-0161 | DOI Listing |
Background: In recent efforts to improve early identification, staging, and prediction of risk of persons at risk for vascular contributions to cognitive impairment and dementia (VCID) in relation with small vessel disease (SVD), the MarkVCID consortium has worked to identify and validate fluid- and imaging-based biomarkers for SVD associated with VCID. Free water (FW) measured derived from diffusion tensor imaging and one of the selected neuroimaging biomarker "kits", has been demonstrated to have excellent instrumental validity and to be a sensitive biomarker of cognitive performances. We sought to further examine FW clinical relevance by investigating whether FW predicts cognitive worsening over time.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Background: Plasma tau phosphorylated at threonine 231 (p-tau231) is a promising novel biomarker of emerging Alzheimer's disease (AD) pathology. We aimed to characterize cross-sectional and longitudinal plasma p-tau231 measurements and estimated ages of biomarker onset in an exceptionally large number of presenilin (PSEN1) E280A (Glu280Ala) mutation carriers and age-matched non-carriers from the Colombian autosomal dominant Alzheimer's disease kindred.
Method: We included a cohort of 722 PSEN1 E280A mutation carriers (mean age 36.
Background: Given the increasing usage of plasma biomarkers for Alzheimer's disease (AD) studies, it is necessary to better understand relationships between plasma biomarker and PET and MR imaging outcomes, particularly within the AT(N) framework.
Method: We evaluated plasma samples from 233 subjects (age 74.05.
Background: Chronic pain leads to tau accumulation and hippocampal atrophy in mice. Tau accumulation in the locus coeruleus (LC) precedes medial temporal accumulation in humans. Here we provide one of the first human studies examining the association of chronic pain with hippocampal volume, LC integrity, and Alzheimer's Disease (AD)-related plasma biomarkers.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, and the New York Presbyterian Hospital, New York, NY, USA.
Background: Small vessel cerebrovascular disease (CVD), visualized as white matter hyperintensities (WMH) on magnetic resonance imaging (MRI), is associated with risk and progression of Alzheimer's disease (AD) in clinical, community, and genetic studies of AD. However, it is unclear whether these observations indicate a role of CVD in AD pathogenesis. One approach towards understanding whether there is a mechanistic or fundamental function of CVD in AD pathogenesis is by examining whether genetic risk factors for AD are also associated with WMH.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!